This is a list of nominated substances that may present significant safety risks in compounding
Symptoms of overmedication include, but are not limited to: rapid or irregular heartbeat, nervousness, irritability or mood swings, muscle weakness or tremors, diarrhea, menstrual irregularities, hair loss, weight loss, insomnia, chest pain, and excessive sweating
May 3, 2025 - The reduced glutathione injection market is estimated at $500 million in 2025, with projections to reach $950 million by 2033, reflecting a strong demand for antioxidant therapies in clinical settings
In biochemical and cellular research systems, DSIP has been examined for its involvement in neuroendocrine signalling, stress-associated pathways, and peptidereceptor interactions